Conni Ciavarella @conniciavarella

Latest posts by conniciavarella.bsky.social on Bluesky

Postdoctoral positions in epidemic mathematical/statistical modelling - Research Job description We are recruiting postdocs to contribute to research projects in the Mathematical Modelling of Infectious Diseases Unit, at Institut Pasteur in Paris. The candidates will be expected t...

New postdoc positions with a number of exciting epidemic modelling projects opening in our Unit at @pasteur.fr in beautiful Paris. Deadline for applications: 26th June.
research.pasteur.fr/en/job/postd...

05.06.2025 05:22 — 👍 55 🔁 66 💬 0 📌 3

In conclusion:

- From a patient perspective, high-dose PQ and TQ is warranted
- From a community perspective, low-dose and high-dose drug regimens will cause similar reductions in P. vivax transmission

Ensuring high drug safety, adherence and coverage is key to maximising PQ and TQ impact.

27.01.2025 10:06 — 👍 2 🔁 0 💬 0 📌 0

We quantified the community-level impact of routinely treating symptomatic P. vivax cases with PQ or TQ using an existing agent-based model.

- All regimens can achieve a similar impact
- Drug adherence and eligibility criteria hamper impact
- Impact decreases with increasing transmission intensity

27.01.2025 10:06 — 👍 3 🔁 0 💬 1 📌 0

We estimated the patient-level efficacy of PQ and TQ by calibrating a novel mathematical model to clinical trial data.

- Effective treatment can eliminate almost all P. vivax hypnozoites
- PQ and TQ regimens have differing efficacies

27.01.2025 10:06 — 👍 0 🔁 0 💬 1 📌 0

Unlike the more common P. falciparum, P. vivax forms dormant liver stage parasites (hypnozoites) that can reactivate weeks to months after primary infection to cause recurrent infections.

The efficacy of liver-stage drugs PQ and TQ cannot be estimated directly because hypnozoites are undetectable.

27.01.2025 10:06 — 👍 0 🔁 0 💬 1 📌 0

Quantifying Plasmodium vivax radical cure efficacy: a modelling study integrating clinical trial data and transmission dynamics Substantial reductions in prevalence as measured by PCR were predicted with primaquine and tafenoquine regimens if these could be implemented with high coverage and adherence. The benefits of preventi...

New paper out in The Lancet Infectious Diseases!

This paper answers questions around the efficacy of primaquine (PQ) and tafenoquine (TQ) against P. vivax malaria.

www.thelancet.com/journals/lan...

27.01.2025 10:06 — 👍 10 🔁 1 💬 1 📌 0

Postdoc (Montpellier, France)
Mathematical modelling of Plasmodium vivax malaria
with @conniciavarella.bsky.social
at @umontpellier.bsky.social
More details: http://iddjobs.org/jobs/2236

24.01.2025 20:36 — 👍 7 🔁 3 💬 0 📌 1

Postdoc (Montpellier, France)
Mathematical/statistical modelling of respiratory virus transmission
with @conniciavarella.bsky.social; @mtsofonea.bsky.social
at @umontpellier.bsky.social
More details: http://iddjobs.org/jobs/2237

24.01.2025 20:38 — 👍 8 🔁 5 💬 0 📌 0

@conniciavarella is following 20 prominent accounts

Suprabhath Kalahasti
@suprabhathk

PhD Candidate (Lab : https://www.evmodelers.org/) | Infectious Disease Modelling | L'école doctorale Pierre Louis de Santé Publique | Sorbonne Centre for Artificial Intelligence (SCAI) Combining #deeplearning with mathematical models of infectious diseas

Pietro Coletti
@pietro-coletti

Assistant Professor UCLouvain. Infectious diseases modelling, social contacts, network epidemiology.

Smriti Mallapaty
@smritimallapaty

Reporter for Nature news, covering the Asia-Pacific region, including infectious diseases, biological and environmental sciences, and community stories (smritidotmallapatyatnaturedotcom) Find me on Signal at sfm.100

Jesus Gomez-Gardeñes
@gomezgardenes

Physicist. Full Professor at University of Zaragoza & GoThAM Lab @gotham-lab.bsky.social. Research on Dynamical Systems and Complex Systems applied to Evolution, Epidemics, Social Behaviors, Sync & much more Website: http://complex.unizar.es/~jesus/

Seth Edmunds
@phealthy

Epidemiology PhD candidate, interested in disease dynamics and novel surveillance systems

Spencer J Fox
@foxandtheflu

Assistant prof at UGA in Epi/Bios, disease modeler, and data scientist. Posts are my own opinions

Amy Hurford
@amyhurford

Professor at Memorial University. Biology Dept, and Mathematics & Statistics Dept. Theoretical Ecology, Evolution and Epidemiology.

Kelsey Shaw
@kesdvm

DVM PhD | Disease ecologist | Postdoctoral fellow at Notre Dame | she/her

Thomas House
@tah-sci.com

Professor of Mathematical Sciences, working mainly on epidemiology although partial to a bit of non-commutative algebra, social science and basic biology. https://personalpages.manchester.ac.uk/staff/thomas.house/about.html

Pleuni Pennings
@pleunipennings

Professor, evolution of drug resistance, modeling, population genetics, coding, SF State University, mom, Dutch

Paolo Bosetti
@paolobosetti

Infectious disease modeller at Institut Pasteur

Natalie Olson, PhD, MPH
@natalieolson

PhD in Environmental Health Sciences 🌿 Infectious Disease Eco-Epidemiology 🌿One Health 🌿 Environmental Justice

Oliver Eales
@eales96

McKenzie Research Fellow at the University of Melbourne. Mathematical modelling of infectious disease dynamics.

Victor Yman
@vyman

Infectious disease physician, post-doc at Institut Pasteur Paris, IDEA Unit. Research on the epidemiology and immunology of vector borne infections, mainly malaria and arboviruses

Carl T. Bergstrom
@carlbergstrom.com

Professor, UW Biology / Santa Fe Institute I study how information flows in biology, science, and society. Book: *Calling Bullshit*, http://tinyurl.com/fdcuvd7b LLM course: https://thebullshitmachines.com Corvids: https://tinyurl.com/mr2n5ymk he/him

Amaia Dominguez Belloso
@amaia-db

Postdoc in @aleksdelab.bsky.social at @pasteur.fr

European Research Council (ERC)
@erc.europa.eu

European Research Council, set up by the EU, funds top researchers of any nationality, helping them pursue great ideas at the frontiers of knowledge. #HorizonEU

@gaellebaudemont

Laura Garcia
@lauragrc

2nd year PhD Student at Institut Pasteur in the G5 - Michael White - Infectious Disease, Analytics & Epidemiology Development of serological assay for surveillance of arboviruses using Luminex Technology

Marc Baguelin
@marcbaguelin

Assoc Prof at Imperial College London and at LSHTM Respiratory viruses, bayesian inference, evidence synthesis, vaccines, outbreak analysis, photographer, urban gardener.